Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (2) Beule, Dieter Dr. (1) Bunse, Mario Dr. (2) Costanza, Mariantonia Dr. (1) Dahlmann, Mathias Dr. (1) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Fischer, Cornelius Dr. (1) Franke, Vedran Dr. (2) Gerhardt, Holger Prof. Dr. (1) Gerlach, Kerstin (5) Höpken, Uta Elisabeth PD Dr. (25) Janz, Martin Dr. (2) Kammertöns, Thomas Dr. (1) Kettritz, Ralph Prof. Dr. (1) Kieback, Elisa Dr. (1) Kobelt, Dennis Dr. (1) Krüger, Kerstin (2) Leutz, Achim Prof. Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (1) Müller, Gerd Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Scheidereit, Claus Prof. Dr. (1) Siffrin, Volker (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (2) Walther, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (2) Wirges, Anthea Dr. (3) (-) Rehm, Armin Dr. (29) 2002 (2) 2003 (1) 2004 (1) 2005 (3) 2007 (1) 2012 (1) 2014 (1) 2016 (2) 2017 (1) 2018 (1) 2019 (1) 2020 (3) 2021 (3) 2022 (7) 2024 (1) Advanced Light Microscopy (3) Bioinformatics and Omics Data Science (1) Biology of Malignant Lymphomas (2) Genome Diversification & Integrity (1) Immune Regulation and Cancer (2) Integrative Vascular Biology (1) Intracellular Proteolysis (2) Mathematical Modelling of Cellular Processes (1) Microenvironmental Regulation in Autoimmunity and Cancer (32) Molecular Cardiovascular Research (2) Molecular Immunology and Gene Therapy (1) Nephrology and Inflammatory Vascular Diseases (1) Neuroimmunology Laboratory (1) Non-coding RNAs and Mechanisms of Cytoplasmic Gene Regulation (1) Proteome Dynamics (1) Translational Bioinformatics (1) Translational Oncology of Solid Tumors (1) (-) Translational Tumorimmunology (29) 29 Results: Active Filter: Rehm, Armin Dr.Translational Tumorimmunology Sort: Result score Newest to oldest Oldest to newest January 23, 2024 / Int J Mol Sci In vitro functionality and endurance of GMP-compliant point-of-care BCMA.CAR-T cells at different timepoints of cryopreservation G. Jiang B. Neuber A. Hückelhoven-Krauss U. Höpken Y. Ding D. Sedloev L. Wang A. Reichman F. Eberhardt M. Wermke A. Rehm C. Müller-Tidow A. Schmitt M. Schmitt November 29, 2022 / Nat Commun Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma F. Cichocki R. Bjordahl J.P. Goodridge S. Mahmood S. Gaidarova R. Abujarour Z.B. Davis A. Merino K. Tuininga H. Wang A. Kumar B. Groff A. Witty G. Bonello J. Huffman T. Dailey T.T. Lee K.J. Malmberg B. Walcheck U. Höpken A. Rehm B. Valamehr J.S. Miller November 02, 2022 / Mol Ther EBAG9-silencing exerts an immune checkpoint function without aggravating adverse effects A. Wirges M. Bunse J.J. Joedicke E. Blanc V. Gudipati M.W. Moles H. Shiku D. Beule J.B. Huppa U.E. Höpken A. Rehm June 17, 2022 / STAR Protoc Analyses of murine lymph node endothelial cell subsets using single-cell RNA sequencing and spectral flow cytometry L. Menzel M. Zschummel A. Rehm June 09, 2022 / Mol Ther Methods Clin Dev Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells J. Kath W. Du A. Pruene T. Braun B. Thommandru R. Turk M.L. Sturgeon G.L. Kurgan L. Amini M. Stein T. Zittel S. Martini L. Ostendorf A. Wilhelm L. Akyüz A. Rehm U.E. Hoepken A. Pruß A. Künkele A.M. Jacobi H.D. Volk M. Schmueck-Henneresse R. Stripecke P. Reinke D.L. Wagner June 08, 2022 / JCI Insight EBAG9 controls CD8(+) T cell memory formation responding to tumor challenge in mice A. Rehm A. Wirges D. Hoser C. Fischer S. Herda K. Gerlach S. Sauer G. Willimsky U.E. Hoepken March 10, 2022 / Mol Ther Methods Clin Dev Accelerating clinical scale production of BCMA CAR T cells with defined maturation stages J.J. Joedicke U. Großkinsky K. Gerlach A. Künkele U.E. Höpken A. Rehm January 14, 2022 / Int J Mol Sci Comparison of FACS and PCR for detection of BCMA-CAR-T cells A. Reichman A. Kunz J.J. Joedicke U.E. Höpken A. Keib B. Neuber D. Sedloev L. Wang G. Jiang A. Hückelhoven-Krauss F. Eberhardt C. Müller-Tidow M. Wermke A. Rehm M. Schmitt A. Schmitt October 26, 2021 / Cell Rep Lymphocyte access to lymphoma is impaired by high endothelial venule regression L. Menzel M. Zschummel T. Crowley V. Franke M. Grau C. Ulbricht A. Hauser V. Siffrin M. Bajénoff S.E. Acton A. Akalin G. Lenz G. Willimsky U.E. Höpken A. Rehm April 01, 2021 / Cell Mol Life Sci MACC1 regulates clathrin-mediated endocytosis and receptor recycling of transferrin receptor and EGFR in colorectal cancer F. Imbastari M. Dahlmann A. Sporbert C. Ciolli Mattioli T. Mari F. Scholz L. Timm S. Twamley R. Migotti W. Walther G. Dittmar A. Rehm U. Stein Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
January 23, 2024 / Int J Mol Sci In vitro functionality and endurance of GMP-compliant point-of-care BCMA.CAR-T cells at different timepoints of cryopreservation G. Jiang B. Neuber A. Hückelhoven-Krauss U. Höpken Y. Ding D. Sedloev L. Wang A. Reichman F. Eberhardt M. Wermke A. Rehm C. Müller-Tidow A. Schmitt M. Schmitt
November 29, 2022 / Nat Commun Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma F. Cichocki R. Bjordahl J.P. Goodridge S. Mahmood S. Gaidarova R. Abujarour Z.B. Davis A. Merino K. Tuininga H. Wang A. Kumar B. Groff A. Witty G. Bonello J. Huffman T. Dailey T.T. Lee K.J. Malmberg B. Walcheck U. Höpken A. Rehm B. Valamehr J.S. Miller
November 02, 2022 / Mol Ther EBAG9-silencing exerts an immune checkpoint function without aggravating adverse effects A. Wirges M. Bunse J.J. Joedicke E. Blanc V. Gudipati M.W. Moles H. Shiku D. Beule J.B. Huppa U.E. Höpken A. Rehm
June 17, 2022 / STAR Protoc Analyses of murine lymph node endothelial cell subsets using single-cell RNA sequencing and spectral flow cytometry L. Menzel M. Zschummel A. Rehm
June 09, 2022 / Mol Ther Methods Clin Dev Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells J. Kath W. Du A. Pruene T. Braun B. Thommandru R. Turk M.L. Sturgeon G.L. Kurgan L. Amini M. Stein T. Zittel S. Martini L. Ostendorf A. Wilhelm L. Akyüz A. Rehm U.E. Hoepken A. Pruß A. Künkele A.M. Jacobi H.D. Volk M. Schmueck-Henneresse R. Stripecke P. Reinke D.L. Wagner
June 08, 2022 / JCI Insight EBAG9 controls CD8(+) T cell memory formation responding to tumor challenge in mice A. Rehm A. Wirges D. Hoser C. Fischer S. Herda K. Gerlach S. Sauer G. Willimsky U.E. Hoepken
March 10, 2022 / Mol Ther Methods Clin Dev Accelerating clinical scale production of BCMA CAR T cells with defined maturation stages J.J. Joedicke U. Großkinsky K. Gerlach A. Künkele U.E. Höpken A. Rehm
January 14, 2022 / Int J Mol Sci Comparison of FACS and PCR for detection of BCMA-CAR-T cells A. Reichman A. Kunz J.J. Joedicke U.E. Höpken A. Keib B. Neuber D. Sedloev L. Wang G. Jiang A. Hückelhoven-Krauss F. Eberhardt C. Müller-Tidow M. Wermke A. Rehm M. Schmitt A. Schmitt
October 26, 2021 / Cell Rep Lymphocyte access to lymphoma is impaired by high endothelial venule regression L. Menzel M. Zschummel T. Crowley V. Franke M. Grau C. Ulbricht A. Hauser V. Siffrin M. Bajénoff S.E. Acton A. Akalin G. Lenz G. Willimsky U.E. Höpken A. Rehm
April 01, 2021 / Cell Mol Life Sci MACC1 regulates clathrin-mediated endocytosis and receptor recycling of transferrin receptor and EGFR in colorectal cancer F. Imbastari M. Dahlmann A. Sporbert C. Ciolli Mattioli T. Mari F. Scholz L. Timm S. Twamley R. Migotti W. Walther G. Dittmar A. Rehm U. Stein